We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Drug Oversight Placed on High-Risk List in GAO Report
FDA Drug Oversight Placed on High-Risk List in GAO Report
January 23, 2009
The FDA should protect the public more effectively by improving its oversight of drugs and biologics, according to a government report that added the agency to a list of operations in need of transformation or at risk for mismanagement.